GOSSAMER BIO, INC.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $16.9M | $-46.7M | $-48.2M | $-38.3M | $-36.6M | $-30.8M | $49.2M | $-41.9M |
| Depreciation & Amortization | — | $5.0K | — | — | $6.0K | $200.0K | $300.0K | $259.0K |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | — | $6.3M | — | — | $2.4M | — | — | $5.8M |
| Net Cash from Operating Activities | $-39.4M | $-38.7M | $-36.2M | $-47.1M | $-39.7M | $-32.0M | $116.3M | $-52.3M |
| Investing Activities | ||||||||
| Capital Expenditures | $0 | $0 | $0 | $53.0K | $26.0K | $0 | $0 | $0 |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | $41.6M | — | — | $22.1M | — | — | $61.7M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | — | $512.0K | — | — | $504.0K | — | — | $-2.6M |
| Net Change in Cash | — | $3.3M | — | — | $-17.1M | — | — | $6.8M |
| Free Cash Flow | $-39.4M | $-38.7M | $-36.2M | $-47.1M | $-39.8M | $-32.0M | $116.3M | $-52.3M |